Literature DB >> 19513375

Effects of ethanol and lipopolysaccharide on the sphingomyelin cycle in rat hepatocytes.

A V Viktorov1, V A Yurkiv.   

Abstract

Lipopolysaccharide toxin added to primary hepatocyte culture slightly modified the basal concentrations of (3)H-serine-labeled sphingomyelin, sphingosine, and ceramide. Ethanol reduced the levels of sphingomyelin and sphingosine by 20-25 and 15-20%, respectively, but increased ceramide content by 7-17%. Tumor necrosis factor reduced the concentrations of sphingomyelin and sphingosine, but did not modify the content of ceramide. Combined treatment with lipopolysaccharide toxin and ethanol potentiated the effect of alcohol.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19513375     DOI: 10.1007/s10517-009-0379-4

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  7 in total

Review 1.  Alcoholic-induced hepatic steatosis--role of ceramide and protein phosphatase 2A.

Authors:  Rodjawan Supakul; Suthat Liangpunsakul
Journal:  Transl Res       Date:  2011-04-20       Impact factor: 7.012

Review 2.  The role of sphingolipids in psychoactive drug use and addiction.

Authors:  Liubov S Kalinichenko; Erich Gulbins; Johannes Kornhuber; Christian P Müller
Journal:  J Neural Transm (Vienna)       Date:  2018-01-10       Impact factor: 3.575

3.  Choline partially prevents the impact of ethanol on the lipid raft dependent functions of l1 cell adhesion molecule.

Authors:  Ningfeng Tang; Penny Bamford; Jace Jones; Min He; Maureen A Kane; Sandra M Mooney; Cynthia F Bearer
Journal:  Alcohol Clin Exp Res       Date:  2014-11       Impact factor: 3.455

4.  Lipidomics for the Prediction of Progressive Liver Disease in Patients with Alcohol Use Disorder.

Authors:  Bei Gao; Suling Zeng; Luca Maccioni; Xiaochun Shi; Aaron Armando; Oswald Quehenberger; Xinlian Zhang; Peter Stärkel; Bernd Schnabl
Journal:  Metabolites       Date:  2022-05-11

5.  Inhibitory effect of ethanol on AMPK phosphorylation is mediated in part through elevated ceramide levels.

Authors:  Suthat Liangpunsakul; Margaret S Sozio; Eric Shin; Zhenwen Zhao; Yan Xu; Ruth A Ross; Yan Zeng; David W Crabb
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-11       Impact factor: 4.052

6.  Alcohol-induced metabolomic differences in humans.

Authors:  M Jaremek; Z Yu; M Mangino; K Mittelstrass; C Prehn; P Singmann; T Xu; N Dahmen; K M Weinberger; K Suhre; A Peters; A Döring; H Hauner; J Adamski; T Illig; T D Spector; R Wang-Sattler
Journal:  Transl Psychiatry       Date:  2013-07-02       Impact factor: 6.222

7.  Insulin resistance, ceramide accumulation, and endoplasmic reticulum stress in human chronic alcohol-related liver disease.

Authors:  Lisa Longato; Kelsey Ripp; Mashiko Setshedi; Miroslav Dostalek; Fatemeh Akhlaghi; Mark Branda; Jack R Wands; Suzanne M de la Monte
Journal:  Oxid Med Cell Longev       Date:  2012-04-22       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.